EDITORIAL   Free access

Minerva Endocrinology 2022 September;47(3):264-9

DOI: 10.23736/S2724-6507.22.03797-6

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Use of adenovirus type-5 vector vaccines in COVID-19: potential implications for metabolic health?

Dimitrios TSILINGIRIS ¹ ✉, Natalia G. VALLIANOU ², Irene KARAMPELA ³, Giovanna MUSCOGIURI ^{4, 5}, Maria DALAMAGA ⁶

¹ First Department of Propedeutic Internal Medicine, School of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece; ² First Department of Internal Medicine, Evangelismos General Hospital, Athens, Greece; ³ Second Department of Critical Care, Medical School, Attikon General University Hospital, National and Kapodistrian University of Athens, Athens, Greece; ⁴ Unit of Endocrinology, Department of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, Naples, Italy; ⁵ Unit of Endocrinology, Department of Clinical Medicine and Surgery, School of Medicine, Centro Italiano per la Cura e il Benessere del Patiente con Obesità (CIBO), University of Naples Federico II, Naples, Italy; ⁶ Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece